Appendix Table 4.
Type of Impact | Included in This Reference Case Analysis From Each Perspective | Notes on Sources of Evidence | |
---|---|---|---|
| |||
Health Care Sector | Societal | ||
Formal health care sector | |||
Health | |||
Health outcomes (effects) | |||
| |||
Longevity effects | Yes | UKPDS OM2, ADA/EASD guidelines | |
| |||
Health-related quality-of-life effects | Yes | Utilities from published literature | |
| |||
Other health effects | No | ||
| |||
Medical costs | |||
Paid for by third-party payers | Yes | Costs from published literature | |
| |||
Paid for by patients out of pocket | No | ||
| |||
Future related medical costs | Yes | Costs from published literature | |
| |||
Future unrelated medical costs | No | ||
| |||
Informal health care sector | |||
Health | |||
Patient-time costs | No | ||
| |||
Unpaid caregiver-time costs | No | ||
| |||
Transportation costs | No | ||
Non–health care sectors | |||
| |||
Productivity | No | ||
| |||
Consumption | No | ||
| |||
Social services | No | ||
| |||
Legal or criminal justice | No | ||
| |||
Education | No | ||
| |||
Housing | No | ||
| |||
Environment | No |
ADA = American Diabetes Association; EASD = European Association for the Study of Diabetes; UKPDS OM2 = United Kingdom Prospective Diabetes Study Outcomes Model 2.